As physician shortages and burnout threaten the patient experience in oncology, The US Oncology Network works to scale ...
A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...
Kura Oncology, Inc. remains a Buy, driven by ziftomenib's launch and promising combination trial data in AML. Learn more ...
Although AI can support complex oncology decision-making, physician judgment remains critical to ensuring safe, ...
Nearly half of people diagnosed with advanced cancer over a recent 5-year period did not undergo next-generation sequencing, according to results of a retrospective cohort study.Rates improved over ...
Zacks Investment Research on MSN
LLY to buy oncology biotech Kelonia Therapeutics for $7 billion
Eli Lilly LLY announced a definitive agreement to acquire Kelonia Therapeutics in a deal valued at up to $7 billion, ...
Expands Nanox’s growing network of U.S. distribution partnerships PETAH TIKVA, Israel, April 23, 2026 (GLOBE NEWSWIRE) -- Nano-X Imaging Ltd. (“Nanox”, or the “Company”, NASDAQ: NNOX), a leader in ...
New Black Book Research report, based on approximately 1,280 qualified U.S. oncology stakeholders, identifies the top-rated ...
Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...
Gilead has struck a deal to buy Germany-based Tubulis for $3.15 billion upfront and up to $1.85 billion in milestones, securing an antibody-drug conjugate (ADC) candidate that is racing toward pivotal ...
Meridian Funds, managed by ArrowMark Partners, released its first-quarter 2026 investor letter for “Meridian Small Cap Growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results